High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: Study protocol for a randomized controlled trial

Trials

Volumn 19, Issue 1, 2018, Pages

  Azoulay, Elie ^a   Lemiale, Virginie ^a   Mokart, Djamel ^b   Nseir, Saad ^c   Argaud, Laurent ^d   Pène, Frédéric ^e   Kontar, Loay ^f   Bruneel, Fabrice ^g   Klouche, Kada ^h   Barbier, François ⁱ   Reignier, Jean ^j   Stoclin, Anabelle ^k   Louis, Guillaume ^l   Constantin, Jean Michel ^m   Mayaux, Julien ⁿ   Wallet, Florent ^o   Kouatchet, Achille ^p   Peigne, Vincent ^q   Perez, Pierre ^r   Girault, Christophe ^s   Jaber, Samir ^t   Oziel, Johanna ^u   Nyunga, Martine ^v   Terzi, Nicolas ^w   Bouadma, Lila ^x   Lebert, Christine ^y   Lautrette, Alexandre ^z   Bigé, Naike ^aa   Raphalen, Jean Herlé ^ab   Papazian, Laurent ^ac   Rabbat, Antoine ^ad   Darmon, Michael ^ae   Chevret, Sylvie ^af   Demoule, Alexandre ⁿ   more..

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g CENTRE HOSPITALIER DE VERSAILLES   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^j HÔTEL DIEU   (France)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l Centre Hospitalier Regional Metz Thionville   (France)

^m UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o Lyon Sud University Medical Hospital   (France)

^p ANGERS UNIVERSITY HOSPITAL   (France)

^q CENTRE HOSPITALIER DE CHAMBÉRY   (France)

^r CHU NANCY BRABOIS   (France)

^s HÔPITAL CHARLES NICOLLE   (France)

^t HÔPITAL SAINT ELOI   (France)

^u AVICENNE HOSPITAL   (France)

^v CENTRE HOSPITALIER DE ROUBAIX   (France)

^w GRENOBLE UNIVERSITY HOSPITAL   (France)

^x BICHAT HOSPITAL   (France)

^y Centre hospitalier Les Oudairies   (France)

^z SERVICE DE RHUMATOLOGIE   (France)

^aa HÔPITAL SAINT ANTOINE   (France)

^ab HÔPITAL NECKER ENFANTS MALADES   (France)

^ac AIX MARSEILLE UNIVERSITY   (France)

^ad Hôpital Cochin ^*  (France)

^ae HÔPITAL NORD   (France)

^af SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Acute respiratory failure; High flow oxygen; Immunocompromised Hematology; Immunosuppression; Intubation; Mortality; Oxygen

Indexed keywords

STEROID;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG MEGADOSE; DYSPNEA; HIGH FLOW NASAL OXYGEN THERAPY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY RATE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; OXYGENATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; CANNULA; DEVICES; EQUIVALENCE TRIAL (TOPIC); FRANCE; IMMUNOLOGY; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY FAILURE; TIME FACTOR;

ACUTE DISEASE; CANNULA; EQUIVALENCE TRIALS AS TOPIC; FRANCE; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; MULTICENTER STUDIES AS TOPIC; OXYGEN INHALATION THERAPY; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY; TIME FACTORS; TREATMENT OUTCOME;

EID: 85043337308     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-018-2492-z     Document Type: Article

References (69)

1. Dumas G, Geri G, Montlahuc C, et al. Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest. 2015;2015(21):14-3098.
2. Faguer S, Ciroldi M, Mariotte E, et al. Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med. 2013;24(3):e40-4.
3. Soares M, Toffart AC, Timsit JF, et al. Intensive care in patients with lung cancer: a multinational study. Ann Oncol. 2014;25(9):1829-35.
4. Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106-14.
5. Azoulay E, Pene F, Darmon M, et al. Managing critically Ill hematology patients: time to think differently. Blood Rev. 2015;2015(26):00030-2.
6. Canet E, Osman D, Lambert J, et al. Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care. 2011;15(2):R91.
7. Murphy G, Lisnevskaia L, Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet. 2013;382(9894):809-18.
8. Guillevin L, Pagnoux C, Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371(19):1771-80.
9. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344(7):481-7.
10. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182(8):1038-46.
11. Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013;54(8):1724-9.
12. Dewan NA, Bell CW. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea. A study comparing the transtracheal catheter and nasal prongs. Chest. 1994;105(4):1061-5.
13. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-96.
14. Stephan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA. 2015;313(23):2331-9.
15. Campbell EJ, Baker MD, Crites-Silver P. Subjective effects of humidification of oxygen for delivery by nasal cannula. A prospective study. Chest. 1988;93(2):289-93.
16. Chanques G, Constantin JM, Sauter M, et al. Discomfort associated with underhumidified high-flow oxygen therapy in critically ill patients. Intensive Care Med. 2009;35(6):996-1003.
17. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005;50(5):604-9.
18. Wagstaff TA, Soni N. Performance of six types of oxygen delivery devices at varying respiratory rates. Anaesthesia. 2007;62(5):492-503.
19. Vargas F, Saint-Leger M, Boyer A, Bui NH, Hilbert G. Physiologic effects of high-flow nasal cannula oxygen in critical care subjects. Respir Care. 2015;2015(5):03814.
20. Itagaki T, Okuda N, Tsunano Y, et al. Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients. Respir Care. 2014;59(1):70-4.
21. Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998-1004.
22. Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011;37(11):1780-6.
23. Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. J Crit Care. 2012;27(3):324. e9-13
24. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103(10):1400-5.
25. Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow oxygen therapy. Respir Care. 2011;56(8):1151-5.
26. Berk JL, Lenner KA, McFadden ER Jr. Cold-induced bronchoconstriction: role of cutaneous reflexes vs. direct airway effects. J Appl Physiol (1985). 1987;63(2):659-64.
27. Fontanari P, Burnet H, Zattara-Hartmann MC, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol (1985). 1996;81(4):1739-43.
28. Chanques G, Riboulet F, Molinari N, et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344-55.
29. Greenspan JS, Wolfson MR, Shaffer TH. Airway responsiveness to low inspired gas temperature in preterm neonates. J Pediatr. 1991;118(3):443-5.
30. Chikata Y, Izawa M, Okuda N, et al. Humidification performance of two high-flow nasal cannula devices: a bench study. Respir Care. 2014;59(8):1186-90.
31. Salah B, Dinh Xuan AT, Fouilladieu JL, Lockhart A, Regnard J. Nasal mucociliary transport in healthy subjects is slower when breathing dry air. Eur Respir J. 1988;1(9):852-5.
32. Negus VE. Humidification of the air passages. Thorax. 1952;7(2):148-51.
33. Groves DS, Durbin CG Jr. Tracheostomy in the critically ill: indications, timing and techniques. Curr Opin Crit Care. 2007;13(1):90-7.
34. Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009;103(6):886-90.
35. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics. 1993;91(1):135-8.
36. Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care. 2011;39(6):1103-10.
37. Volsko TA, Fedor K, Amadei J, Chatburn RL. High flow through a nasal cannula and CPAP effect in a simulated infant model. Respir Care. 2011;56(12):1893-900.
38. Riera J, Perez P, Cortes J, Roca O, Masclans JR, Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013;58(4):589-96.
39. Corley A, Bull T, Spooner AJ, Barnett AG, Fraser JF. Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI ≥ 30: a randomised controlled trial. Intensive Care Med. 2015;41(5):887-94.
40. Maggiore SM, Idone FA, Vaschetto R, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282-8.
41. Vourc'h M, Asfar P, Volteau C, et al. High-flow nasal cannula oxygen during endotracheal intubation in hypoxemic patients: a randomized controlled clinical trial. Intensive Care Med. 2015;2015:14.
42. Kang BJ, Koh Y, Lim CM, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41(4):623-32.
43. Messika J, Ben Ahmed K, Gaudry S, et al. Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care. 2015;60(2):162-9.
44. Parke R, McGuinness S, Dixon R, Jull A. Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients. Br J Anaesth. 2013;111(6):925-31.
45. Lucangelo U, Vassallo FG, Marras E, et al. High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012(506382):506382.
46. Simon M, Braune S, Frings D, Wiontzek AK, Klose H, Kluge S. High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy-a prospective randomised trial. Crit Care. 2014;18(6):712.
47. Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013;58(10):1621-4.
48. Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55(4):408-13.
49. Rello J, Perez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care. 2012;27(5):434-9.
50. Nagata K, Morimoto T, Fujimoto D, et al. Efficacy of high-flow nasal cannula therapy in acute hypoxemic respiratory failure: decreased use of mechanical ventilation. Respir Care. 2015;2015(23):04026.
51. Lenglet H, Sztrymf B, Leroy C, Brun P, Dreyfuss D, Ricard JD. Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy. Respir Care. 2013;57(11):1873-8.
52. Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department. Respir Care. 2015;2015(9):03837.
53. Futier E, Paugam-Burtz C, Constantin JM, Pereira B, Jaber S. The OPERA trial - comparison of early nasal high flow oxygen therapy with standard care for prevention of postoperative hypoxemia after abdominal surgery: study protocol for a multicenter randomized controlled trial. Trials. 2013;14(341):341.
54. Miguel-Montanes R, Hajage D, Messika J, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med. 2015;43(3):574-83.
55. Tiruvoipati R, Lewis D, Haji K, Botha J. High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care. 2010;25(3):463-8.
56. Brotfain E, Zlotnik A, Schwartz A, et al. Comparison of the effectiveness of high flow nasal oxygen cannula vs. standard non-rebreather oxygen face mask in post-extubation intensive care unit patients. Isr Med Assoc J. 2014;16(11):718-22.
57. Lee HY, Rhee CK, Lee JW. Feasibility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematologic malignancies: a retrospective single-center study. J Crit Care. 2015;30(4):773-7.
58. Epstein AS, Hartridge-Lambert SK, Ramaker JS, Voigt LP, Portlock CS. Humidified high-flow nasal oxygen utilization in patients with cancer at Memorial Sloan-Kettering Cancer Center. J Palliat Med. 2011;14(7):835-9.
59. Hui D, Morgado M, Chisholm G, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manag. 2013;46(4):463-73.
60. Roca O, de Acilu MG, Caralt B, Sacanell J, Masclans JR. Humidified high flow nasal cannula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure. Transplantation. 2015;99(5):1092-8.
61. Peters SG, Holets SR, Gay PC. High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care. 2013;58(4):597-600.
62. Mokart D, Geay C, Chow-Chine L, et al. High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med. 2015;2015:4.
63. Lemiale V, Resche-Rigon M, Azoulay E. Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial. Trials. 2015;15(372):372.
64. Kaji AH, Lewis RJ. Noninferiority trials: is a New Treatment almost as effective as another? JAMA. 2015;313(23):2371-2.
65. Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early NIV averts extubation failure in patients at risk trial. Am J Respir Crit Care Med. 2006;173(2):164-70.
66. Coudroy R, Jamet A, Petua P, Robert R, Frat JP, Thille A. High-flow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure: an observational cohort study. Ann Intensive Care. 2016;6(1):45.
67. Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW. REVA network. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med. 2016;4(8):646-52.
68. Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, van de Louw A, Hemelaar P, Lemiale V, Taccone FS, Martin Loeches I, Meyhoff TS, Salluh J, Schellongowski P, Rusinova K, Terzi N, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Landburg PP, Bruneel F, Bukan RB, Pène F, Metaxa V, Moreau AS, Souppart V, Burghi G, Girault C, Uva S, Montini L, Barbier F, Nielsen LB, Gaborit B, Mokart D, Chevret S, Efraim investigators and the Nine-I study group. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med. 2017;43(12):1808-19.
69. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-40.